MAFA
NVO

MJT & Associates Financial Advisory’s Novo Nordisk NVO Stock Holding History

MJT & Associates Financial Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Hold
224
– – 0.01% 192
2026
Q1 		$8.23K Hold
224
– – 0.01% 201
2025
Q4 		$11.4K Hold
224
– – 0.01% 175
2025
Q3 		$12.4K Hold
224
– – 0.01% 170
2025
Q2 		$15.5K Hold
224
– – 0.02% 173
2025
Q1 		$15.6K Buy
+224
New +$18.5K 0.01% 165

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MJT & Associates Financial Advisory's NVO Position: Q2 2026 in Review

MJT & Associates Financial Advisory held its Novo Nordisk (NVO) position steady in Q2 2026 at 224 shares worth $10.7K. The position accounts for 0.01% of the portfolio, ranked #192.

MJT & Associates Financial Advisory first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.6K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MJT & Associates Financial Advisory held 224 shares of Novo Nordisk worth $10.7K as of Q2 2026.
  • MJT & Associates Financial Advisory left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #192 holding.
  • MJT & Associates Financial Advisory first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • MJT & Associates Financial Advisory's Novo Nordisk position peaked at $15.6K in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.